Market research
SOLY Soliton Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 488M
- P/E ratio
- Not available
- Analyst target
- 22.6
- Dividend yield
- 0.0%
- Beta
- 0.18
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US8342511008
- Market cap
- 488M
- P/E ratio
- Not available
- Analyst target
- 22.6
- Dividend yield
- 0.0%
- Beta
- 0.18
About
About Soliton Inc
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas. As of December 16, 2021, Soliton, Inc. operates as a subsidiary of Allergan plc.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the SOLY discussion.
5 years, 4 months ago
Soliton, Inc is currently in a long term uptrend where the price is trading 60.7% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Soliton, Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 38.7% to $-5M since the same quarter in the previous year.
Finally, its free cash flow fell by 29.5% to $-3M since the same quarter in the previous year.
Based on the above factors, Soliton, Inc gets an overall score of 2/5.